0.69
전일 마감가:
$0.69
열려 있는:
$0.695
하루 거래량:
158.85K
Relative Volume:
0.58
시가총액:
$12.87M
수익:
$174.80K
순이익/손실:
$-8.85M
주가수익비율:
-1.0019
EPS:
-0.6887
순현금흐름:
$-4.37M
1주 성능:
-3.14%
1개월 성능:
-14.97%
6개월 성능:
-31.68%
1년 성능:
-78.16%
Nexalin Technology Inc Stock (NXL) Company Profile
명칭
Nexalin Technology Inc
전화
(832) 260-0222
주소
1776 YORKTOWN, HOUSTON
NXL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
NXL
Nexalin Technology Inc
|
0.69 | 12.87M | 174.80K | -8.85M | -4.37M | -0.6887 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Nexalin Technology Inc 주식(NXL)의 최신 뉴스
Aug Update: Does Nexalin Technology Inc have consistent dividend growth2025 Big Picture & Low Drawdown Investment Ideas - baoquankhu1.vn
Nexalin Technology Inc. (NXL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Market Moves: Is Nexalin Technology Inc stock forming a cup and handleWeekly Gains Report & AI Enhanced Trading Alerts - baoquankhu1.vn
Trading Action: Is Nexalin Technology Inc Equity Warrant forming a double bottomJuly 2025 PreEarnings & AI Forecast Swing Trade Picks - baoquankhu1.vn
Can Nexalin Technology Inc Equity Warrant outperform in the next rallyTake Profit & Weekly Top Stock Performers List - baoquankhu1.vn
Drug-free brain stimulation eases adult ADHD and calms overactive activity - Stock Titan
Aug Sectors: Will Nexalin Technology Inc stock benefit from M AJuly 2025 PostEarnings & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Published on: 2026-01-10 20:28:51 - Улправда
HOKA Model Insights: Why Nexalin Technology Inc. stock attracts high net worth investorsPerformance Line Overview & support options for steady strides - Улправда
Is Nexalin Technology Inc. Equity Warrant stock undervalued vs historical averagesTraining Rotation Ideas & stability guidance for smoother miles - ulpravda.ru
Why Nexalin Technology Inc. Equity Warrant stock appeals to dividend seekers2025 Trading Volume Trends & Safe Swing Trade Setups - Улправда
Is Nexalin Technology Inc. stock a top pick in earnings season2025 EndofYear Setup & Daily Profit Focused Screening - Улправда
Why Nexalin Technology Inc. stock attracts high net worth investorsWeekly Market Outlook & High Accuracy Swing Trade Signals - Улправда
Nexalin Technology, Inc.Common Stock (NQ: NXL - FinancialContent
Is Nexalin Technology Inc a good long term investmentFibonacci Retracement Levels & Free Technical Analysis and Insights - Early Times
Nexalin Technology announces effective registration statement - MSN
Returns Recap: Why Nexalin Technology Inc stock remains resilientDay Trade & Verified High Yield Trade Plans - Bộ Nội Vụ
Can Nexalin Technology Inc. Equity Warrant stock deliver strong Q4 earnings2025 Trading Recap & Daily Oversold Stock Bounce Ideas - Улправда
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Daily Commercial
Why retail investors favor Nexalin Technology Inc. Equity Warrant stock2025 Trading Recap & Free Community Supported Trade Ideas - Улправда
Will Nexalin Technology Inc. stock outperform value stocksEarnings Trend Report & Low Risk High Win Rate Picks - Улправда
How Nexalin Technology Inc. Equity Warrant stock performs after earnings2025 Price Momentum & Weekly High Momentum Picks - Улправда
Nexalin Technology Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Is Nexalin Technology Inc. Equity Warrant stock a safe haven assetQuarterly Market Summary & Risk Adjusted Buy/Sell Alerts - ulpravda.ru
Fed Watch: Is Nexalin Technology Inc. stock supported by innovation pipeline2025 Price Momentum & Technical Confirmation Trade Alerts - Улправда
Is Nexalin Technology Inc. Equity Warrant stock in correction or buying zoneProduct Launch & Verified Momentum Stock Watchlist - Улправда
Why Nexalin Technology Inc. stock could be next big winner2025 Price Momentum & Free Real-Time Volume Trigger Notifications - DonanımHaber
Is Nexalin Technology Inc. stock a dividend growth opportunityWeekly Gains Summary & Verified Entry Point Detection - Улправда
Will Nexalin Technology Inc. Equity Warrant stock deliver consistent dividendsMarket Growth Review & Stock Timing and Entry Methods - DonanımHaber
Is Nexalin Technology Inc. stock supported by innovation pipelineJuly 2025 Big Picture & Daily Technical Stock Forecast Reports - Улправда
Can Nexalin Technology Inc. Equity Warrant stock beat market expectations this quarter2025 Key Highlights & Expert Approved Trade Ideas - DonanımHaber
Will Nexalin Technology Inc. stock maintain growth storyTrade Risk Assessment & Safe Entry Point Alerts - Улправда
VIX Spike: Is Nexalin Technology Inc. Equity Warrant stock a safe haven assetJuly 2025 Macro Moves & Free Community Consensus Stock Picks - Улправда
Why Nexalin Technology Inc. stock is favored by pension fundsJuly 2025 Drop Watch & Technical Entry and Exit Alerts - Улправда
RSI Check: Will Nexalin Technology Inc. stock maintain growth storyJuly 2025 Pullbacks & Smart Money Movement Alerts - Улправда
Nexalin Technology (NASDAQ:NXL) Shares Down 10.9% – Time to Sell? - Defense World
What analysts say about Nexalin Technology Inc Equity Warrant stockEarnings Miss Alerts & Superior Capital Trading Plans - earlytimes.in
Market Overview: Will Nexalin Technology Inc stock outperform value stocksTrade Entry Report & Low Risk Investment Opportunities - moha.gov.vn
Nexalin Technology unveils new investor presentation on DIFS - MSN
Nexalin Technology Unveils New Investor Presentation on DIFS - TipRanks
Nexalin Technology, Inc. Unveils Advanced Neurostimulation Technology - TradingView — Track All Markets
Will Nexalin Technology Inc. Equity Warrant stock reach Wall Street targetsTreasury Yields & Real-Time Stock Entry Alerts - Newser
Nexalin advances Alzheimer’s device after FDA meeting By Investing.com - Investing.com South Africa
Nexalin Technology completes FDA Q-submission meeting for Gen-2 Sync - marketscreener.com
Nexalin advances Alzheimer’s device after FDA meeting - Investing.com
Nexalin Technology Completes FDA Q-Submission Meeting for - GlobeNewswire
Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC™ Neurostimulation Console in Alzheimer’s Disease Program - Sahm
Nexalin Technology (Nasdaq: NXL) wraps FDA Q-Sub, plans U.S. pilot Alzheimer’s study - Stock Titan
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4 - markets.businessinsider.com
How Nexalin Technology Inc. stock trades before earnings2025 Trading Recap & Risk Controlled Stock Alerts - Newser
Nexalin Technology Inc (NXL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Nexalin Technology Inc 주식 (NXL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory |
Mar 12 '25 |
Buy |
2.20 |
6,000 |
13,200 |
30,000 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
3.10 |
1,000 |
3,100 |
155,793 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
2.98 |
1,000 |
2,980 |
154,793 |
| Owens David | Chief Medical Officer |
Jan 28 '25 |
Buy |
2.70 |
1,500 |
4,050 |
153,793 |
| Owens David | Chief Medical Officer |
Jan 23 '25 |
Buy |
2.70 |
1,000 |
2,700 |
152,293 |
자본화:
|
볼륨(24시간):